In Phase I trials, a modest number of healthy volunteers are involved.
They are designed to assess the safety of the new treatment in order to determine whether or not it creates adverse effects.
In the case of new medications, a safe dose range is determined, and any potential adverse effects are recognised.
Typically, this phase lasts a few months.